
    
      The exceedingly high mortality rates of severe and critical COVID-19 warrant the evaluation
      of novel therapies that could potentially mitigate the advanced disease manifestations. In
      this context, is proposes a prospective multicenter study. It will include 15 patients, to
      assess the feasibility and efficacy of low-dose lung irradiation in COVID-19 pneumonia.
    
  